IDEXX Laboratories, Inc. (IDXX)
USD 404.65
(3.51%)
USD 404.65
(3.51%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 380.28 Million USD | 3.39% |
| 2022 | 367.82 Million USD | 36.72% |
| 2021 | 269.03 Million USD | 28.19% |
| 2020 | 209.87 Million USD | 7.62% |
| 2019 | 195.01 Million USD | 12.53% |
| 2018 | 173.3 Million USD | 5.47% |
| 2017 | 164.31 Million USD | 3.98% |
| 2016 | 158.03 Million USD | -16.31% |
| 2015 | 188.83 Million USD | 17.77% |
| 2014 | 160.34 Million USD | 20.17% |
| 2013 | 133.42 Million USD | -5.33% |
| 2012 | 140.94 Million USD | 5.9% |
| 2011 | 133.09 Million USD | 4.08% |
| 2010 | 127.88 Million USD | 15.81% |
| 2009 | 110.42 Million USD | -4.75% |
| 2008 | 115.92 Million USD | 17.33% |
| 2007 | 98.8 Million USD | 2.93% |
| 2006 | 95.99 Million USD | 38.38% |
| 2005 | 69.36 Million USD | -9.23% |
| 2004 | 76.42 Million USD | 1.45% |
| 2003 | 75.33 Million USD | 0.33% |
| 2002 | 75.08 Million USD | -12.89% |
| 2001 | 86.19 Million USD | 30.73% |
| 2000 | 65.93 Million USD | 38.81% |
| 1999 | 47.5 Million USD | -14.26% |
| 1998 | 55.4 Million USD | -7.97% |
| 1997 | 60.2 Million USD | 24.38% |
| 1996 | 48.4 Million USD | 71.63% |
| 1995 | 28.2 Million USD | 35.58% |
| 1994 | 20.8 Million USD | 42.47% |
| 1993 | 14.6 Million USD | 14.06% |
| 1992 | 12.8 Million USD | 150.98% |
| 1991 | 5.1 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 389.8 Million USD | 2.59% |
| 2024 Q2 | 379.95 Million USD | -2.72% |
| 2024 Q1 | 390.59 Million USD | 2.71% |
| 2023 Q4 | 380.28 Million USD | -3.48% |
| 2023 FY | 380.28 Million USD | 3.39% |
| 2023 Q3 | 393.97 Million USD | -0.3% |
| 2023 Q2 | 395.14 Million USD | 1.06% |
| 2023 Q1 | 391.01 Million USD | 6.3% |
| 2022 Q1 | 301.63 Million USD | 12.12% |
| 2022 Q4 | 367.82 Million USD | 3.62% |
| 2022 FY | 367.82 Million USD | 36.72% |
| 2022 Q3 | 354.97 Million USD | 6.74% |
| 2022 Q2 | 332.56 Million USD | 10.25% |
| 2021 Q2 | 241.39 Million USD | 7.02% |
| 2021 FY | 269.03 Million USD | 28.19% |
| 2021 Q4 | 269.03 Million USD | 4.08% |
| 2021 Q3 | 258.48 Million USD | 7.08% |
| 2021 Q1 | 225.55 Million USD | 7.47% |
| 2020 Q4 | 209.87 Million USD | -3.55% |
| 2020 FY | 209.87 Million USD | 7.62% |
| 2020 Q3 | 217.59 Million USD | -5.14% |
| 2020 Q2 | 229.37 Million USD | 8.38% |
| 2020 Q1 | 211.64 Million USD | 8.52% |
| 2019 Q3 | 204.89 Million USD | 4.07% |
| 2019 FY | 195.01 Million USD | 12.53% |
| 2019 Q4 | 195.01 Million USD | -4.82% |
| 2019 Q2 | 196.87 Million USD | 3.91% |
| 2019 Q1 | 189.46 Million USD | 9.33% |
| 2018 FY | 173.3 Million USD | 5.47% |
| 2018 Q4 | 173.3 Million USD | -3.55% |
| 2018 Q3 | 179.68 Million USD | 1.81% |
| 2018 Q2 | 176.48 Million USD | -1.43% |
| 2018 Q1 | 179.03 Million USD | 8.96% |
| 2017 Q1 | 172.18 Million USD | 8.95% |
| 2017 FY | 164.31 Million USD | 3.98% |
| 2017 Q4 | 164.31 Million USD | -7.03% |
| 2017 Q3 | 176.74 Million USD | 4.16% |
| 2017 Q2 | 169.69 Million USD | -1.45% |
| 2016 Q4 | 158.03 Million USD | -6.19% |
| 2016 Q3 | 168.46 Million USD | -4.11% |
| 2016 FY | 158.03 Million USD | -16.31% |
| 2016 Q2 | 175.68 Million USD | -4.39% |
| 2016 Q1 | 183.75 Million USD | -2.69% |
| 2015 Q3 | 192.4 Million USD | 4.28% |
| 2015 Q4 | 188.83 Million USD | -1.86% |
| 2015 Q2 | 184.5 Million USD | 6.42% |
| 2015 FY | 188.83 Million USD | 17.77% |
| 2015 Q1 | 173.37 Million USD | 8.13% |
| 2014 Q4 | 160.34 Million USD | 2.78% |
| 2014 Q1 | 141.13 Million USD | 5.78% |
| 2014 FY | 160.34 Million USD | 20.17% |
| 2014 Q3 | 156 Million USD | 7.3% |
| 2014 Q2 | 145.4 Million USD | 3.02% |
| 2013 Q1 | 148.24 Million USD | 5.18% |
| 2013 Q3 | 145.98 Million USD | 3.58% |
| 2013 Q4 | 133.42 Million USD | -8.6% |
| 2013 FY | 133.42 Million USD | -5.33% |
| 2013 Q2 | 140.93 Million USD | -4.93% |
| 2012 FY | 140.94 Million USD | 5.9% |
| 2012 Q1 | 141.1 Million USD | 6.01% |
| 2012 Q2 | 143.7 Million USD | 1.84% |
| 2012 Q4 | 140.94 Million USD | -4.43% |
| 2012 Q3 | 147.47 Million USD | 2.62% |
| 2011 Q1 | 127.05 Million USD | -0.65% |
| 2011 FY | 133.09 Million USD | 4.08% |
| 2011 Q4 | 133.09 Million USD | -2.95% |
| 2011 Q3 | 137.14 Million USD | 2.4% |
| 2011 Q2 | 133.93 Million USD | 5.42% |
| 2010 Q3 | 131.55 Million USD | 7.8% |
| 2010 FY | 127.88 Million USD | 15.81% |
| 2010 Q4 | 127.88 Million USD | -2.79% |
| 2010 Q2 | 122.03 Million USD | -0.29% |
| 2010 Q1 | 122.38 Million USD | 10.83% |
| 2009 Q4 | 110.42 Million USD | -11.3% |
| 2009 FY | 110.42 Million USD | -4.75% |
| 2009 Q3 | 124.48 Million USD | 1.27% |
| 2009 Q2 | 122.92 Million USD | -0.53% |
| 2009 Q1 | 123.57 Million USD | 6.6% |
| 2008 Q4 | 115.92 Million USD | 2.67% |
| 2008 Q3 | 112.9 Million USD | 6.33% |
| 2008 Q2 | 106.18 Million USD | 6.31% |
| 2008 Q1 | 99.87 Million USD | 1.09% |
| 2008 FY | 115.92 Million USD | 17.33% |
| 2007 Q4 | 98.8 Million USD | 2.63% |
| 2007 FY | 98.8 Million USD | 2.93% |
| 2007 Q2 | 91.55 Million USD | -13.93% |
| 2007 Q3 | 96.27 Million USD | 5.16% |
| 2007 Q1 | 106.37 Million USD | 10.81% |
| 2006 FY | 95.99 Million USD | 38.38% |
| 2006 Q1 | 81.22 Million USD | 17.1% |
| 2006 Q2 | 85.54 Million USD | 5.31% |
| 2006 Q3 | 93.24 Million USD | 9.0% |
| 2006 Q4 | 95.99 Million USD | 2.95% |
| 2005 Q4 | 69.36 Million USD | -13.51% |
| 2005 FY | 69.36 Million USD | -9.23% |
| 2005 Q1 | 78.48 Million USD | 2.69% |
| 2005 Q2 | 81.76 Million USD | 4.18% |
| 2005 Q3 | 80.2 Million USD | -1.91% |
| 2004 Q3 | 85.99 Million USD | 8.99% |
| 2004 Q4 | 76.42 Million USD | -11.13% |
| 2004 FY | 76.42 Million USD | 1.45% |
| 2004 Q1 | 75.86 Million USD | 0.7% |
| 2004 Q2 | 78.9 Million USD | 4.01% |
| 2003 FY | 75.33 Million USD | 0.33% |
| 2003 Q4 | 75.33 Million USD | 8.71% |
| 2003 Q1 | 69.38 Million USD | -7.6% |
| 2003 Q3 | 69.29 Million USD | -0.72% |
| 2003 Q2 | 69.8 Million USD | 0.6% |
| 2002 Q4 | 75.08 Million USD | -0.15% |
| 2002 Q2 | 75.54 Million USD | -11.28% |
| 2002 Q1 | 85.14 Million USD | -1.22% |
| 2002 FY | 75.08 Million USD | -12.89% |
| 2002 Q3 | 75.19 Million USD | -0.45% |
| 2001 FY | 86.19 Million USD | 30.73% |
| 2001 Q3 | 83.84 Million USD | 5.45% |
| 2001 Q2 | 79.51 Million USD | 2.6% |
| 2001 Q1 | 77.49 Million USD | 17.53% |
| 2001 Q4 | 86.19 Million USD | 2.81% |
| 2000 Q3 | 62.87 Million USD | 10.79% |
| 2000 Q4 | 65.93 Million USD | 4.88% |
| 2000 Q1 | 47.18 Million USD | -0.66% |
| 2000 FY | 65.93 Million USD | 38.81% |
| 2000 Q2 | 56.74 Million USD | 20.26% |
| 1999 Q2 | 47.5 Million USD | 1.5% |
| 1999 Q4 | 47.5 Million USD | -1.86% |
| 1999 FY | 47.5 Million USD | -14.26% |
| 1999 Q3 | 48.4 Million USD | 1.89% |
| 1999 Q1 | 46.8 Million USD | -15.52% |
| 1998 Q1 | 55.8 Million USD | -7.31% |
| 1998 Q3 | 43 Million USD | -15.69% |
| 1998 Q4 | 55.4 Million USD | 28.84% |
| 1998 FY | 55.4 Million USD | -7.97% |
| 1998 Q2 | 51 Million USD | -8.6% |
| 1997 Q4 | 60.2 Million USD | -4.44% |
| 1997 FY | 60.2 Million USD | 24.38% |
| 1997 Q1 | 60.9 Million USD | 25.83% |
| 1997 Q2 | 71.3 Million USD | 17.08% |
| 1997 Q3 | 63 Million USD | -11.64% |
| 1996 FY | 48.4 Million USD | 71.63% |
| 1996 Q4 | 48.4 Million USD | 18.05% |
| 1996 Q2 | 40.2 Million USD | 20.36% |
| 1996 Q3 | 41 Million USD | 1.99% |
| 1996 Q1 | 33.4 Million USD | 18.44% |
| 1995 Q4 | 28.2 Million USD | 11.02% |
| 1995 Q1 | 24.7 Million USD | 18.75% |
| 1995 FY | 28.2 Million USD | 35.58% |
| 1995 Q3 | 25.4 Million USD | -7.3% |
| 1995 Q2 | 27.4 Million USD | 10.93% |
| 1994 Q2 | 20 Million USD | 9.29% |
| 1994 Q1 | 18.3 Million USD | 25.34% |
| 1994 FY | 20.8 Million USD | 42.47% |
| 1994 Q4 | 20.8 Million USD | 0.0% |
| 1994 Q3 | 20.8 Million USD | 4.0% |
| 1993 FY | 14.6 Million USD | 14.06% |
| 1993 Q4 | 14.6 Million USD | 5.04% |
| 1993 Q3 | 13.9 Million USD | 9.45% |
| 1993 Q2 | 12.7 Million USD | -3.79% |
| 1993 Q1 | 13.2 Million USD | 3.13% |
| 1992 Q2 | 11.6 Million USD | 12.62% |
| 1992 Q1 | 10.3 Million USD | 101.96% |
| 1992 Q4 | 12.8 Million USD | 3.23% |
| 1992 FY | 12.8 Million USD | 150.98% |
| 1992 Q3 | 12.4 Million USD | 6.9% |
| 1991 Q3 | 4.6 Million USD | -2.13% |
| 1991 FY | 5.1 Million USD | 0.0% |
| 1991 Q2 | 4.7 Million USD | 0.0% |
| 1991 Q4 | 5.1 Million USD | 10.87% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Aspira Women's Health Inc. | 227 Thousand USD | -167425.11% |
| bioAffinity Technologies, Inc. | 18.48 Thousand USD | -2057257.715% |
| Intelligent Bio Solutions Inc. | 777.53 Thousand USD | -48808.541% |
| Standard BioTools Inc. | 20.53 Million USD | -1752.053% |
| Inotiv, Inc. | 56.1 Million USD | -577.84% |
| Prenetics Global Limited | 3.12 Million USD | -12062.112% |
| Neuronetics, Inc. | 8.09 Million USD | -4598.9% |
| Star Equity Holdings, Inc. | 3.42 Million USD | -11019.357% |
| Castle Biosciences, Inc. | 7.94 Million USD | -4688.24% |
| Psychemedics Corporation | 1.00 USD | -38028199900.0% |
| RadNet, Inc. | 1.00 USD | -38028199900.0% |
| Exact Sciences Corporation | 127.47 Million USD | -198.319% |
| iSpecimen Inc. | - USD | -Infinity% |
| OpGen, Inc. | 1.00 USD | -38028199900.0% |
| Exagen Inc. | 2.87 Million USD | -13145.629% |
| Bionano Genomics, Inc. | 22.89 Million USD | -1561.128% |
| CareDx, Inc | 19.47 Million USD | -1853.069% |
| Check-Cap Ltd. | - USD | -Infinity% |
| Twist Bioscience Corporation | 32.06 Million USD | -1086.046% |
| Guardant Health, Inc. | 61.94 Million USD | -513.873% |
| Biodesix, Inc. | 1.4 Million USD | -27063.0% |
| BioNexus Gene Lab Corp. | 1.13 Million USD | -33323.451% |
| Precipio, Inc. | 384 Thousand USD | -98931.771% |
| Natera, Inc. | 40.75 Million USD | -833.001% |
| Fulgent Genetics, Inc. | 5.82 Million USD | -6426.206% |
| Sera Prognostics, Inc. | - USD | -Infinity% |
| 23andMe Holding Co. | 12.46 Million USD | -2950.798% |
| OPKO Health, Inc. | 65.69 Million USD | -478.842% |
| Personalis, Inc. | 5.66 Million USD | -6617.576% |
| Aclaris Therapeutics, Inc. | - USD | -Infinity% |
| Applied DNA Sciences, Inc. | 330.02 Thousand USD | -115127.542% |
| T2 Biosystems, Inc. | 4.81 Million USD | -7791.305% |
| Neogen Corporation | 189.26 Million USD | -100.924% |
| Myriad Genetics, Inc. | 20.1 Million USD | -1791.95% |
| ICON Public Limited Company | 1.00 USD | -38028199900.0% |
| NeoGenomics, Inc. | 24.15 Million USD | -1474.276% |
| Star Equity Holdings, Inc. | 3.42 Million USD | -11019.357% |
| MDxHealth SA | 2.77 Million USD | -13584.131% |
| Prenetics Global Limited | 3.12 Million USD | -12062.112% |
| Illumina, Inc. | 587 Million USD | 35.216% |
| DarioHealth Corp. | 5.06 Million USD | -7412.485% |
| ENDRA Life Sciences Inc. | 2.62 Million USD | -14398.726% |
| Medpace Holdings, Inc. | 1.00 USD | -38028199900.0% |
| Mainz Biomed B.V. | 613.63 Thousand USD | -61871.716% |
| Trinity Biotech plc | 19.93 Million USD | -1807.801% |
| Sotera Health Company | 51.98 Million USD | -631.523% |
| bioAffinity Technologies, Inc. | 18.48 Thousand USD | -2057257.715% |